Key Drivers
- Margin Expansion
- Cash Generation
- Intangible Drag
AIAI Summary
LIVN now looks more like a credible growth-and-margin recovery story than a pure turnaround, but investors should discount the headline EPS beat because it was helped by one-time tax/tariff items and lower free-cash-flow guidance, making sustained revenue growth, margin expansion, and cash conversion the real proof points before any rerating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Cash Generation
- •Intangible Drag
LIVN's latest quarter showed improving operating momentum with strong margins and cash flow, but earnings quality and valuation remain constrained by tax-driven profits, legacy losses, and a heavy intangible asset load.
Price Behavior
Key Price Behavior Insights:
- •Failed breakout
- •Support rebound
- •Overhead resistance
Over the last month, LIVN has been range-bound, rebounding from a failed breakout and support near $76–$78, but it still needs a decisive move above $83–$85 to turn constructive.
Sharp rejection after a push to $85.33, followed by a drop to $75.78 and rebound back into the low $80s
Sentiment & News
Key News Insights:
- •Record Q2
- •Raised Guidance
- •FCF Pressure
LivaNova posted record Q2 results with double-digit growth, beat estimates, and raised 2026 guidance, though higher investment lowered free-cash-flow outlook.
The stronger-than-expected quarter and improved outlook should support positive investor sentiment, even as increased spending tempers near-term cash flow
Similar Companies in Healthcare
Other companies in the same sector with AI ratings